TheDiArc Exclusive

Launch of Shoe Line Under Christina DiArcangelo – Get To See The Wonderful Shoe Products Under CD

Christina DiArcangelo has launched a wonderful shoe line with...

Health/Patient Advocacy In Publich Sector Of US – TheDiArc.Com

Although most individuals believe they grasp the notion of...

TheDiArc Magazine August 2022 Edition – Christina DiArcangelo – World Leaders – Cannabinoid – Telemonitoring

TheDiArc Magazine August 2022 Edition has been published. In...

Clinical Trial With Christina DiArcangelo – TheDiArc.Com

Before participating in a clinical trial, it is critical to understand what a clinical study is and what you may anticipate as a participant.

A clinical trial may be defined in several different ways.

Researchers use clinical trial to test new medicines and learn more about how patients’ health issues might be treated. A wide variety of objectives are served by Clinical Research In Health Sector (US). Drug efficacy is be tested, as well as the effects of various treatments on health outcomes, therapeutic products, devices, using clinical tests. All experiments are aimed at improving screening, diagnosing, and treating disease while proving efficacy and safety.

Some therapies that patients would otherwise be unable to get are made accessible to them as a result of their participation in clinical trials. For one thing, it permits parents to enroll their children into clinical studies rather than using products off label as prescribed by their physician. Medical breakthroughs may be made for patients who participate in research in certain instances.

There is a particular question that each clinical study aims to solve. Some studies need the participation of healthy individuals. Others need volunteers with a specific medical condition or group of medical issues. An individual’s eligibility for a clinical trial is determined by a set of criteria known as inclusion criteria. Exclusion criteria are the grounds used to exclude someone from clinical research. Christina DiArcangelo may wish to include or exclude individuals depending on their age, gender, current health issues, and other variables. Researchers benefit from the criterion since it ensures the safety of participants while giving them the data set they need to get the best findings.

Latest

The DiArc Magazine – An Exclusive Lifestyle Magazine| January 2023 | Edition 09 | Christina DiArcangelo

TheDiArc Magazine January 2023 Edition has been published. In this edition we are bringing the best articles as always. We have an Exclusive Interview with Joe Lewis who does decals for vehicles by the name of Royal Customs.

Zelira Therapeutics Completes Enrolment For Diabetic Nerve Pain Drug Trial With Affinity Bio Partners

It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialisation of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organisation, have completed enrolment for a diabetic nerve pain drug trial.

CANNABIS – The Revival of an Ancient Women’s Herb With Shabnam

Cannabis - the revival of an ancient women's herb From Egyptian antiquity to the fifteenth century, women relied on a vast knowledge of medicinal plants for their health. Herbal formulations for regulating their fertility, facilitating childbirth, and  intensifying orgasm, to name a few!

Listen to your Gut with Chelsea Haines

My name is Chelsea Haines, I am the founder and CEO of the Gut Health Agency. I have  years of accolades that warrant me credit to share what I’m about to share with you regarding human behaviour and gut health

Newsletter

Don't miss

The DiArc Magazine – An Exclusive Lifestyle Magazine| January 2023 | Edition 09 | Christina DiArcangelo

TheDiArc Magazine January 2023 Edition has been published. In this edition we are bringing the best articles as always. We have an Exclusive Interview with Joe Lewis who does decals for vehicles by the name of Royal Customs.

Zelira Therapeutics Completes Enrolment For Diabetic Nerve Pain Drug Trial With Affinity Bio Partners

It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialisation of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organisation, have completed enrolment for a diabetic nerve pain drug trial.

CANNABIS – The Revival of an Ancient Women’s Herb With Shabnam

Cannabis - the revival of an ancient women's herb From Egyptian antiquity to the fifteenth century, women relied on a vast knowledge of medicinal plants for their health. Herbal formulations for regulating their fertility, facilitating childbirth, and  intensifying orgasm, to name a few!

Listen to your Gut with Chelsea Haines

My name is Chelsea Haines, I am the founder and CEO of the Gut Health Agency. I have  years of accolades that warrant me credit to share what I’m about to share with you regarding human behaviour and gut health

How did a stigmatized housewife make it on the NJ Insider 100?

DiAnA was the Community Outreach Specialist for one of the Original 12 license holders a vertically integrated MSO in New Jersey.
Christina DiArcangelo
Christina DiArcangelohttp://www.christinadiarcangelo.com
Christina DiArcangelo has forged a world-class reputation in the Biotechnology and Pharmaceutical industry for the past 22 years. Her engagements have led to numerous industry awards, keynote speaking engagements, TV and media appearances, a multitude of global clinical trials as well as working on several drugs that have received FDA approval and the ultimate respect of her industry peers. Throughout the course of Christina's career, she has acted in various capacities for Global Clinical Research Organizations, Pharmaceutical Companies and Biotechnology Companies.

The DiArc Magazine – An Exclusive Lifestyle Magazine| January 2023 | Edition 09 | Christina DiArcangelo

TheDiArc Magazine January 2023 Edition has been published. In this edition we are bringing the best articles as always. We have an Exclusive Interview with Joe Lewis who does decals for vehicles by the name of Royal Customs.

Zelira Therapeutics Completes Enrolment For Diabetic Nerve Pain Drug Trial With Affinity Bio Partners

It’s an exciting time in the medical cannabis community as Zelira, a global leader in the research, development and commercialisation of clinically validated cannabinoid medicines, and Affinity Bio Partners, a leading, global clinical research organisation, have completed enrolment for a diabetic nerve pain drug trial.

CANNABIS – The Revival of an Ancient Women’s Herb With Shabnam

Cannabis - the revival of an ancient women's herb From Egyptian antiquity to the fifteenth century, women relied on a vast knowledge of medicinal plants for their health. Herbal formulations for regulating their fertility, facilitating childbirth, and  intensifying orgasm, to name a few!